THERAPEUTIC EFFICACY OF RU 28965 IN RESPIRATORY TRACT INFECTIONS

RU 28965, a new macrolide antibiotic, was orally administered to 24 patients with upper and lower respiratory tract infections. Clinical response was excellent in 1, good in 12, fair in 4 and poor in 7 cases. Skin rash was observed in one patient, and slight elevation of transaminase in three.

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 36; no. Supplement4; pp. 245 - 250
Main Authors AONUMA, SEIICHI, TOKUE, YUTAKA, KITAMURA, NAOTO, HONDA, YOSHIHIRO, ONO, REIKO, WATANABE, AKIRA, SASAKI, MASAKO, OIZUMI, KOTARO, KONNO, KIYOSHI, NAKAI, YUSHI, SAITO, JUNICHI, NAGAI, KOSAKU
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1988
Online AccessGet full text

Cover

More Information
Summary:RU 28965, a new macrolide antibiotic, was orally administered to 24 patients with upper and lower respiratory tract infections. Clinical response was excellent in 1, good in 12, fair in 4 and poor in 7 cases. Skin rash was observed in one patient, and slight elevation of transaminase in three.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.36.Supplement4_245